Vanda Pharmaceuticals buy BiotechBee
Start price
24.12.23
/
60%
€3.70
Target price
31.08.25
€5.00
Performance (%)
20.54%
Price
30.04.24
€4.46
Summary
This prediction is currently active. The prediction currently has a performance of 20.54%. This prediction currently runs until 31.08.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vanda Pharmaceuticals | 2.765% | 2.765% |
iShares Core DAX® | -0.992% | -3.231% |
iShares Nasdaq 100 | -0.225% | -3.339% |
iShares Nikkei 225® | -0.736% | -7.859% |
iShares S&P 500 | -0.509% | -2.979% |
According to BiotechBee what are the pros and cons of Vanda Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Buy mit Kursziel 5,0